ATG-201

ATG-201 is a novel T-cell engager (TCE). ATG-201 exhibits CD19-dependent CD3 binding and activation properties, enabling the effective depletion of B cells. ATG-201 can be used to study B-cell malignancies and B-cell-related autoimmune diseases.

For research use only. We do not sell to patients.

  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00